Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-05-12

Clinical Trial Update: The Effect of Gabapentin (Neurentin) and Pregabalin (Lyrica) in Pain Reduction After Photorefractive Keratectomy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigates whether gabapentin and pregabalin can reduce pain following photorefractive keratectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Neurontin) (gabapentin)
  • Pregabalin (Lyrica) (pregabalin)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Refractive Errors | Phase 1 | Status: UNKNOWN